Ironwood Pharmaceuticals (IRWD) EPS (Basic) Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 678.17 Mn | 599.04 Mn | - | 113.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.80% |
| Mar 31, 2026 | 207.40% |
| Dec 31, 2025 | -203.77% |
| Sep 30, 2025 | 975.50% |
| Jun 30, 2025 | 2,798.10% |
| Mar 31, 2025 | -784.25% |
| Dec 31, 2024 | 203.96% |
| Sep 30, 2024 | -74.29% |
| Jun 30, 2024 | 99.92% |
| Mar 31, 2024 | -108.87% |
| Dec 31, 2023 | -214.21% |
| Sep 30, 2023 | -72.81% |
| Jun 30, 2023 | -2,999.29% |
| Mar 31, 2023 | 20.39% |
| Dec 31, 2022 | 221.32% |
| Sep 30, 2022 | -4.20% |
| Jun 30, 2022 | -89.99% |
| Mar 31, 2022 | -0.96% |
| Dec 31, 2021 | -10.75% |
| Jun 30, 2021 | -98.47% |